Management & Advisory Board

Patient Portal

Management Board

Mr. Lal L. Chellaram

Chairman, The Chellaram Foundation. Qualified as an Economist from London University. He is an Entrepreneur and a Philanthropist. He is also the Chairman of the Chellaram Group. Mr. Chellaram initiated the Group’s diversification into Ship Owning and Ship Operations in the late 70’s. He established the Chellaram Foundation in India and several Charities worldwide

Mr. Prakash Bhoopatkar

Chartered Accountant and a Management Consultant, Trustee and Vice-Chairman of Chellaram Foundation . He has had an international career in Management at the most senior levels in Finance and Organisation Development working in India, Hong Kong , Gibraltar and New Zealand. He is a Director and Vice Chairman of a range of organisations across a number of business segments

Mr. Sankara Narayanan

Chartered Accountant, with Kaycee Group

Dr.A.G.Unnikrishnan

MD, DM (Endocrinology), DNB, MNAMS. Dr AG Unnikrishnan is a renowned endocrinologist and CEO of Chellaram Diabetes Institute. Formerly the Professor of Endocrinology at Amrita Institute, he has published the largest multicenter study of subjects with pancreatitis and pancreatic diabetes, in addition to his more than 90 indexed publications. He has received the Subash Mukherjee Oration award of the Endocrine Society of India, and the Srivastava Award of the RSSDI (India’s largest diabetes society) for his contribution to diabetes in India. He has also received the Jacob Memorial Prize for the best patient care awarded by the Christian Medical College, Vellore, in 1998.

Mr. Vandan Agrawal

A Chartered Accountant with vast experience in various aspects of Finance & Accounts and General Administration in different industries.

Dr.Anil Pandit

Experienced Qualified Hosp Administrator from Defence back ground with academic & administrative experience of about 41 years. He has got experience of PG Teaching (Pune University Recognised PG Teacher & Examiner), Examiner for DNB in Hosp Admin of National Exam Board of India. Recognised Professor in Hospital Administration by MCI. PhD Guide & Examiner in Healthcare & Hospital Administration
Former Prof & HOD, MBA (HHM) at SIHS (Symbiosis International University, Pune)
Presently, Chief Medical Director, Chellaram Diabetes Institute, Pune

Advisory Board

Dr. H. B. Chandalia

MD, FACP, Founder and Director, Diabetes Endocrine Nutrition Management and Research Centre, India and Consultant Diabetologist and Endocrinologist at Jaslok Hospital/Lilavati Hospital/Bhatia and Breach Candy Hospitals. Formerly on the faculty of University of Alabama School of Medicine, Birmingham, USAI am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Dr (Col) Mrinal kanti Mandal

Joined Chellaram Diabetes Institute in 2010 with 30 years of rich experience in Clinical Practice and Hospital Administration in the Armed Forces. A Medical graduate (MBBS) & MD from Armed Forces Medical College (AFMC), Pune with a Management Degree (MMS) from Osmania University. A NABH Assessor & an alumnus of College of Defense Management, Secunderabad, he was a Post Graduate Teacher (Ass Prof & Prof) & Examiner of Hospital Administration in AFMC & MUHS. Has unique distinction of commanding & administering two Hospitals in Kashmir, including setting up & running a Multi speciality Hospital in strife torn Congo for United Nations.

Dr. C. B. Sanjeevi

MD, M.Sc, Ph.D., Associate Professor, Karolinska Institute, Diabetes and Endocrinology Division and Head, Molecular Immunogenetics Group, Centre for Molecular Medicine

Dr. Ananda Basu

Dr. Ananda Basu is the Harrison Professor in the Division of Endocrinology at the University of Virginia. He is the past Chair of the Hospital Diabetes Practice at Mayo Clinic. Dr. Basu is currently the Principal Investigator of two NIH funded projects- NIDDK-DP3-106785 that attempts to recreate a truly electronic beta cell by infusing insulin and amylin and NIDDK-R01-085516 that seeks to understand the altered physiology of the alpha cell in humans with and without type 1 diabetes. He is also a consultant in a project that seeks to introduce the first indigenous artificial pancreas for patients with type 1 diabetes. Dr. Basu is the author of almost 200 peer-reviewed publications in major journals including the New England Journal of Medicine, Journal of Clinical Investigation and Diabetes. He has been on the editorial board of Diabetes Care and currently is an Associate editor of the Diabetes Technology and Therapeutics journal.